Advertisement
Advertisement

ONCY

ONCY logo

Oncolytics Biotech, Inc. Common Shares

0.95
USD
Sponsored
+0.03
+2.99%
Jun 26, 15:58 UTC -4
Closed
exchange

After-Market

0.94

0.00
-0.30%

ONCY Earnings Reports

Positive Surprise Ratio

ONCY beat 22 of 39 last estimates.

56%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.10
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
+42.86%

Oncolytics Biotech, Inc. Common Shares earnings per share and revenue

On May 01, 2026, ONCY reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.10 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q2 26, 2 analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Oncolytics Biotech, Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 2 analysts, Oncolytics Biotech, Inc. Common Shares is expected to report EPS of -$0.10 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement